Phibro Animal Health Corporation is a leading global animal health and mineral nutrition company that provides solutions to enhance the health and productivity of livestock and companion animals. The company operates through three primary segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment is the core of the business, accounting for approximately 74% of total revenue in fiscal 2025, and offers medicated feed additives (MFAs) such as antibacterials and anticoccidials, nutritional specialty products, and vaccines for poultry, swine, cattle, and aquaculture. The Mineral Nutrition segment (around 20% of revenue) provides trace minerals that fortify animal diets, while the Performance Products segment manufactures specialty ingredients for the personal care, industrial chemical, and chemical catalyst industries. Geographically, the United States is Phibro's largest market, generating over half of its net sales, with a significant and growing international presence in Latin America, EMEA, and the Asia-Pacific region. The company's competitive position is bolstered by its extensive global manufacturing footprint, deep scientific expertise, and strategic acquisitions, such as the recent integration of Zoetis's medicated feed additive portfolio.
